MAZE Maze Therapeutics, Inc. Sotuvning operatsion marjasi

Maze Therapeutics Inc - MAZE emitenti grafik logotipi

Maze Therapeutics Inc (MAZE) dividendlar to'lamaydi, buning o'rniga robotlashtirilgan sintez va AI asosidagi molekulyar dizaynga investitsiyalar kiritmoqda. Operatsion daromadlilik tarixi ishonch ko'rsatkichi vazifasini o'taydi va ushbu metrika -820.80 darajasida qayd etilgan. Samaradorlik bulutli serverlar va Compass platformasiga asoslangan bo'lsa-da, bloklangan M&A kelishuvi startapni organik o'sishni ta'minlash uchun yangi litsenziyalash hamkorlarini qidirishga majbur qilmoqda.

MAZE: mazetx.com Operatsion faoliyat rentabelligi 01.02.2025 - 20.11.2026

MAZE (Maze Therapeutics): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar

- bozor kapitallashuvi bo'yicha ma'lumotlar:
Kompaniyaning fundamental baholanishi:Maze Therapeutics Corp, MAZE
mazetx.com asosiy tovari

Operatsion marja moliyaviy xarajatlar va soliqlardan oldingi umumiy tushumda asosiy operatsiyalardan olingan foyda ulushini ifodalaydi. Ushbu ko'rsatkich xarajatlarni boshqarish samaradorligini va biznes modelining hayotiyligini baholaydi. Maze Therapeutics Inc (MAZE) uchun ushbu metrika preklinik ishlanmalar davrida hisoblash platformasini litsenziyalashning daromadliligini aks ettiradi. Moslashtirilgan operatsion marjani tahlil qilish B2B oqimlarining barqarorligini kuzatish imkonini beradi. Ijobiy dinamika uning genetik texnologiyalarining tijorat miqyosidagi kengayish imkoniyatlarini tasdiqlaydi.

Raqobatchilar tahlili

Sotuvning operatsion marjasi TEM|QGEN - Operatsion foyda bo'yicha marjinallik|Operatsion marja IONS|RGEN - Sotuvning operatsion rentabelligi|Operatsion rentabellik Avidity RNA|Operatsion marja CRISPR Therapeutics Corp CRSP|GeneDx Corp - Operatsion marja|Ultragenyx Pharma (RARE) - Sotuvning operatsion marjasi|beamtx.com (BEAM) - Operatsion rentabellik|SRPT: Operatsion foyda koeffitsiyenti|Sotuvning operatsion marjasi TWST|TXG - Operatsion foyda bo'yicha marjinallik|Operatsion marja NTLA|Operatsion faoliyat rentabelligi Stoke Therapeutics|Operatsion rentabellik BioLife Solutions BLFS|Wave Life Sciences (WVE) - Sotuvning operatsion rentabelligi|Sionna Therapeutics, Inc. - Operatsion marja|Operatsion foyda normasi PRME (Prime Medicine Inc)|TSHA (Taysha Gene Therapies, Inc.) - Sotuvning operatsion marjasi|QURE - Operatsion faoliyat rentabelligi|MGTX (MeiraGTx Corp) - Operatsion marja|Sotuvning operatsion rentabelligi REGENXBIO Inc. RGNX|Operatsion rentabellik Solid Biosciences (SLDB)|Ocugen Corp - Operatsion foyda bo'yicha sotuv rentabelligi|Operatsion rentabellik Pacific Biosciences PACB|Operatsion foyda koeffitsiyenti BNTC (Benitec)|Design Corp - Operatsion marja|Rocket Pharmaceuticals - Operatsion foyda koeffitsiyenti|Operatsion foyda bo'yicha sotuv rentabelligi 4D Molecular Therapeutics, Inc.|Sotuvning operatsion rentabelligi Lexeo Therapeutics (LXEO)|KRRO (Korro Bio, Inc.) - Operatsion marja|Sotuvning operatsion rentabelligi Editas EDIT|Operatsion marja SLN|ProQR Therapeutics - Operatsion foyda bo'yicha sotuv rentabelligi|Operatsion marja CDXS (Codexis, Inc.)|SGMO: Operatsion foyda bo'yicha sotuv rentabelligi|Nautilus Biotechnology - Operatsion marja|Operatsion foyda normasi MGX (Metagenomi, Inc)|DTIL: Operatsion marja|GBIO: Operatsion foyda koeffitsiyenti|Operatsion rentabellik Boundless Bio Inc.|Sotuvning operatsion marjasi Exicure (XCUR)|Operatsion marja IMNN|PHIO (Phio Pharmaceuticals Corp.) - Operatsion foyda normasi|Mustang Bio, Inc. - Sotuvning operatsion marjasi|RNAZ - Sotuvning operatsion marjasi|BNGO: Sotuvning operatsion marjasi|APDN (Applied DNA Sciences Inc) - Operatsion foyda bo'yicha sotuv rentabelligi|BLUE (Bluebird Bio) - Sotuvning operatsion marjasi|ImmunoPrecise Antibodies Ltd - Operatsion foyda normasi|OMGA (Omega Therapeutics Inc) - Operatsion marja|Operatsion rentabellik OMIC|Operatsion rentabellik Regulus Therapeutics Inc. (RGLS)|Sotuvning operatsion marjasi Syros Pharmaceuticals, Inc. SYRS|Telesis Bio - Sotuvning operatsion marjasi|Operatsion foyda normasi TCON|UBX - Operatsion rentabellik